In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...
Stephen Freedland, MD, of Cedars-Sinai, discussed enzalutamide and leuprolide's potential to improve overall survival without ...
Precipitation and humidity can render a standard paper target unusable in only seconds, which is what makes Rite In The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback